Related Experiment Videos
Biocompatible benzocyclobutene (BCB)-based neural implants with micro-fluidic channel
Keekeun Lee1, Jiping He, Ryan Clement
1Department of Electrical Engineering, Center for Solid State Electronics Research, Arizona State University, Tempe, AZ 85287-5706, USA. keekeun@asu.edu
Biosensors & Bioelectronics
|August 17, 2004
Summary
This study presents a flexible, biocompatible poly-benzocyclobutene (BCB) neural implant with integrated micro-fluidic channels for drug delivery. The device successfully recorded neural signals in rats, demonstrating its potential for chronic neural interfacing.
Area of Science:
- Biomaterials Engineering
- Neuroscience
- Medical Devices
Background:
- Chronic neural implants require biocompatible, flexible materials for long-term use.
- Delivering therapeutics directly to neural tissue is challenging.
- Poly-benzocyclobutene (BCB) offers promising properties for neural applications.
Purpose of the Study:
- To fabricate and evaluate a novel poly-benzocyclobutene (BCB)-based intracortical neural implant.
- To integrate micro-fluidic channels for targeted drug delivery.
- To assess the implant's biocompatibility, mechanical robustness, and neural recording capabilities.
Main Methods:
- Fabrication of a single-shank BCB implant with integrated micro-fluidic channels and recording sites.
- In vitro cytotoxicity testing on cultured cells.
- Mechanical testing to evaluate penetration robustness in rat pia.
- Impedance measurements at 1 kHz.
- In vivo neural signal recording from rat barrel cortex.
Main Results:
- The BCB implant demonstrated flexibility, biocompatibility, and chemical inertness.
- In vitro tests showed no adverse toxic effects.
- The implant, reinforced with a silicon backbone, successfully penetrated the rat pia without buckling.
- Average impedance at 1 kHz was 1.2 MΩ.
- Simultaneous neural signal recordings were successfully achieved in vivo.
Conclusions:
- BCB-based neural implants with embedded micro-fluidic channels are feasible for chronic applications.
- The fabricated implant exhibits suitable properties for neural interfacing and drug delivery.
- The device demonstrates potential for simultaneous neural recording and therapeutic delivery in the brain.